nodes	percent_of_prediction	percent_of_DWPC	metapath
Budesonide—NR3C1—Medroxyprogesterone Acetate—uterine cancer	0.204	0.509	CbGbCtD
Budesonide—NR3C1—Progesterone—uterine cancer	0.135	0.337	CbGbCtD
Budesonide—Flurandrenolide—Medroxyprogesterone Acetate—uterine cancer	0.0638	0.132	CrCrCtD
Budesonide—Hydrocortamate—Medroxyprogesterone Acetate—uterine cancer	0.0597	0.123	CrCrCtD
Budesonide—Prednicarbate—Medroxyprogesterone Acetate—uterine cancer	0.0561	0.116	CrCrCtD
Budesonide—Hydrocortamate—Progesterone—uterine cancer	0.0521	0.107	CrCrCtD
Budesonide—Testolactone—Progesterone—uterine cancer	0.0489	0.101	CrCrCtD
Budesonide—Fluorometholone—Medroxyprogesterone Acetate—uterine cancer	0.0467	0.0963	CrCrCtD
Budesonide—Methylprednisolone—Medroxyprogesterone Acetate—uterine cancer	0.0436	0.09	CrCrCtD
Budesonide—Hydrocortisone—Medroxyprogesterone Acetate—uterine cancer	0.041	0.0845	CrCrCtD
Budesonide—Prednisolone—Progesterone—uterine cancer	0.0372	0.0768	CrCrCtD
Budesonide—Hydrocortisone—Progesterone—uterine cancer	0.0357	0.0737	CrCrCtD
Budesonide—CYP3A4—Medroxyprogesterone Acetate—uterine cancer	0.0284	0.071	CbGbCtD
Budesonide—CYP3A4—Progesterone—uterine cancer	0.0188	0.0471	CbGbCtD
Budesonide—CYP3A4—Etoposide—uterine cancer	0.00842	0.0211	CbGbCtD
Budesonide—CYP3A4—Doxorubicin—uterine cancer	0.00574	0.0144	CbGbCtD
Budesonide—Testolactone—CYP19A1—uterine cancer	0.000575	0.337	CrCbGaD
Budesonide—Betamethasone—PGR—uterine cancer	0.000329	0.193	CrCbGaD
Budesonide—Dexamethasone—CYP11A1—uterine cancer	0.000254	0.149	CrCbGaD
Budesonide—Betamethasone—CYP19A1—uterine cancer	0.000226	0.132	CrCbGaD
Budesonide—Dexamethasone—PGR—uterine cancer	0.000191	0.112	CrCbGaD
Budesonide—Dexamethasone—CYP19A1—uterine cancer	0.000131	0.0769	CrCbGaD
Budesonide—Gastrointestinal pain—Dactinomycin—uterine cancer	0.000107	0.000942	CcSEcCtD
Budesonide—Vomiting—Medroxyprogesterone Acetate—uterine cancer	0.000107	0.000939	CcSEcCtD
Budesonide—Increased appetite—Doxorubicin—uterine cancer	0.000106	0.000937	CcSEcCtD
Budesonide—Migraine—Epirubicin—uterine cancer	0.000106	0.000936	CcSEcCtD
Budesonide—Affect lability—Epirubicin—uterine cancer	0.000106	0.000936	CcSEcCtD
Budesonide—Rash—Medroxyprogesterone Acetate—uterine cancer	0.000106	0.000932	CcSEcCtD
Budesonide—Dermatitis—Medroxyprogesterone Acetate—uterine cancer	0.000106	0.000931	CcSEcCtD
Budesonide—Headache—Medroxyprogesterone Acetate—uterine cancer	0.000105	0.000926	CcSEcCtD
Budesonide—Malaise—Etoposide—uterine cancer	0.000105	0.000922	CcSEcCtD
Budesonide—Face oedema—Epirubicin—uterine cancer	0.000104	0.000918	CcSEcCtD
Budesonide—Vertigo—Etoposide—uterine cancer	0.000104	0.000918	CcSEcCtD
Budesonide—Purpura—Doxorubicin—uterine cancer	0.000104	0.000913	CcSEcCtD
Budesonide—Abdominal pain—Dactinomycin—uterine cancer	0.000103	0.000911	CcSEcCtD
Budesonide—Body temperature increased—Dactinomycin—uterine cancer	0.000103	0.000911	CcSEcCtD
Budesonide—Mood swings—Epirubicin—uterine cancer	0.000102	0.000901	CcSEcCtD
Budesonide—Loss of consciousness—Etoposide—uterine cancer	0.000102	0.000898	CcSEcCtD
Budesonide—Cough—Etoposide—uterine cancer	0.000101	0.000892	CcSEcCtD
Budesonide—Hypertension—Etoposide—uterine cancer	0.0001	0.000882	CcSEcCtD
Budesonide—Nausea—Medroxyprogesterone Acetate—uterine cancer	9.95e-05	0.000878	CcSEcCtD
Budesonide—Chest pain—Etoposide—uterine cancer	9.87e-05	0.00087	CcSEcCtD
Budesonide—Abdominal pain upper—Epirubicin—uterine cancer	9.85e-05	0.000869	CcSEcCtD
Budesonide—Affect lability—Doxorubicin—uterine cancer	9.82e-05	0.000866	CcSEcCtD
Budesonide—Migraine—Doxorubicin—uterine cancer	9.82e-05	0.000866	CcSEcCtD
Budesonide—Hypokalaemia—Epirubicin—uterine cancer	9.82e-05	0.000866	CcSEcCtD
Budesonide—Unspecified disorder of skin and subcutaneous tissue—Etoposide—uterine cancer	9.8e-05	0.000864	CcSEcCtD
Budesonide—Discomfort—Etoposide—uterine cancer	9.75e-05	0.00086	CcSEcCtD
Budesonide—Breast disorder—Epirubicin—uterine cancer	9.75e-05	0.00086	CcSEcCtD
Budesonide—Nasopharyngitis—Epirubicin—uterine cancer	9.65e-05	0.000851	CcSEcCtD
Budesonide—Face oedema—Doxorubicin—uterine cancer	9.64e-05	0.00085	CcSEcCtD
Budesonide—Hypersensitivity—Dactinomycin—uterine cancer	9.63e-05	0.000849	CcSEcCtD
Budesonide—Confusional state—Etoposide—uterine cancer	9.54e-05	0.000841	CcSEcCtD
Budesonide—Anaphylactic shock—Etoposide—uterine cancer	9.46e-05	0.000834	CcSEcCtD
Budesonide—Mood swings—Doxorubicin—uterine cancer	9.46e-05	0.000834	CcSEcCtD
Budesonide—Infection—Etoposide—uterine cancer	9.4e-05	0.000829	CcSEcCtD
Budesonide—Abdominal distension—Epirubicin—uterine cancer	9.39e-05	0.000828	CcSEcCtD
Budesonide—Asthenia—Dactinomycin—uterine cancer	9.38e-05	0.000827	CcSEcCtD
Budesonide—Influenza—Epirubicin—uterine cancer	9.32e-05	0.000822	CcSEcCtD
Budesonide—Tachycardia—Etoposide—uterine cancer	9.23e-05	0.000814	CcSEcCtD
Budesonide—Skin disorder—Etoposide—uterine cancer	9.19e-05	0.00081	CcSEcCtD
Budesonide—Hyperhidrosis—Etoposide—uterine cancer	9.14e-05	0.000806	CcSEcCtD
Budesonide—Abdominal pain upper—Doxorubicin—uterine cancer	9.12e-05	0.000804	CcSEcCtD
Budesonide—Hypokalaemia—Doxorubicin—uterine cancer	9.08e-05	0.000801	CcSEcCtD
Budesonide—Breast disorder—Doxorubicin—uterine cancer	9.02e-05	0.000795	CcSEcCtD
Budesonide—Anorexia—Etoposide—uterine cancer	9.02e-05	0.000795	CcSEcCtD
Budesonide—Bronchitis—Epirubicin—uterine cancer	8.97e-05	0.000791	CcSEcCtD
Budesonide—Diarrhoea—Dactinomycin—uterine cancer	8.94e-05	0.000789	CcSEcCtD
Budesonide—Nasopharyngitis—Doxorubicin—uterine cancer	8.93e-05	0.000787	CcSEcCtD
Budesonide—Dysuria—Epirubicin—uterine cancer	8.72e-05	0.000769	CcSEcCtD
Budesonide—Abdominal distension—Doxorubicin—uterine cancer	8.68e-05	0.000766	CcSEcCtD
Budesonide—Influenza—Doxorubicin—uterine cancer	8.63e-05	0.000761	CcSEcCtD
Budesonide—Pollakiuria—Epirubicin—uterine cancer	8.61e-05	0.00076	CcSEcCtD
Budesonide—Paraesthesia—Etoposide—uterine cancer	8.49e-05	0.000749	CcSEcCtD
Budesonide—Weight increased—Epirubicin—uterine cancer	8.48e-05	0.000748	CcSEcCtD
Budesonide—Dyspnoea—Etoposide—uterine cancer	8.43e-05	0.000744	CcSEcCtD
Budesonide—Somnolence—Etoposide—uterine cancer	8.41e-05	0.000742	CcSEcCtD
Budesonide—Infestation NOS—Epirubicin—uterine cancer	8.31e-05	0.000733	CcSEcCtD
Budesonide—Infestation—Epirubicin—uterine cancer	8.31e-05	0.000733	CcSEcCtD
Budesonide—Vomiting—Dactinomycin—uterine cancer	8.31e-05	0.000733	CcSEcCtD
Budesonide—Bronchitis—Doxorubicin—uterine cancer	8.3e-05	0.000732	CcSEcCtD
Budesonide—Rash—Dactinomycin—uterine cancer	8.24e-05	0.000727	CcSEcCtD
Budesonide—Decreased appetite—Etoposide—uterine cancer	8.22e-05	0.000725	CcSEcCtD
Budesonide—Gastrointestinal disorder—Etoposide—uterine cancer	8.17e-05	0.00072	CcSEcCtD
Budesonide—Fatigue—Etoposide—uterine cancer	8.15e-05	0.000719	CcSEcCtD
Budesonide—Pain—Etoposide—uterine cancer	8.09e-05	0.000713	CcSEcCtD
Budesonide—Constipation—Etoposide—uterine cancer	8.09e-05	0.000713	CcSEcCtD
Budesonide—Conjunctivitis—Epirubicin—uterine cancer	8.08e-05	0.000713	CcSEcCtD
Budesonide—Urinary tract infection—Epirubicin—uterine cancer	8.08e-05	0.000713	CcSEcCtD
Budesonide—Dysuria—Doxorubicin—uterine cancer	8.07e-05	0.000711	CcSEcCtD
Budesonide—Pollakiuria—Doxorubicin—uterine cancer	7.97e-05	0.000703	CcSEcCtD
Budesonide—Haematuria—Epirubicin—uterine cancer	7.93e-05	0.000699	CcSEcCtD
Budesonide—Weight increased—Doxorubicin—uterine cancer	7.85e-05	0.000692	CcSEcCtD
Budesonide—Epistaxis—Epirubicin—uterine cancer	7.84e-05	0.000691	CcSEcCtD
Budesonide—Sinusitis—Epirubicin—uterine cancer	7.8e-05	0.000688	CcSEcCtD
Budesonide—Feeling abnormal—Etoposide—uterine cancer	7.79e-05	0.000687	CcSEcCtD
Budesonide—Nausea—Dactinomycin—uterine cancer	7.76e-05	0.000685	CcSEcCtD
Budesonide—Gastrointestinal pain—Etoposide—uterine cancer	7.73e-05	0.000682	CcSEcCtD
Budesonide—Infestation—Doxorubicin—uterine cancer	7.69e-05	0.000678	CcSEcCtD
Budesonide—Infestation NOS—Doxorubicin—uterine cancer	7.69e-05	0.000678	CcSEcCtD
Budesonide—Urticaria—Etoposide—uterine cancer	7.51e-05	0.000663	CcSEcCtD
Budesonide—Haemoglobin—Epirubicin—uterine cancer	7.5e-05	0.000661	CcSEcCtD
Budesonide—Rhinitis—Epirubicin—uterine cancer	7.48e-05	0.00066	CcSEcCtD
Budesonide—Body temperature increased—Etoposide—uterine cancer	7.48e-05	0.000659	CcSEcCtD
Budesonide—Abdominal pain—Etoposide—uterine cancer	7.48e-05	0.000659	CcSEcCtD
Budesonide—Urinary tract infection—Doxorubicin—uterine cancer	7.48e-05	0.000659	CcSEcCtD
Budesonide—Conjunctivitis—Doxorubicin—uterine cancer	7.48e-05	0.000659	CcSEcCtD
Budesonide—Haemorrhage—Epirubicin—uterine cancer	7.46e-05	0.000658	CcSEcCtD
Budesonide—Pharyngitis—Epirubicin—uterine cancer	7.41e-05	0.000653	CcSEcCtD
Budesonide—Urinary tract disorder—Epirubicin—uterine cancer	7.37e-05	0.00065	CcSEcCtD
Budesonide—Oedema peripheral—Epirubicin—uterine cancer	7.35e-05	0.000648	CcSEcCtD
Budesonide—Haematuria—Doxorubicin—uterine cancer	7.33e-05	0.000647	CcSEcCtD
Budesonide—Connective tissue disorder—Epirubicin—uterine cancer	7.33e-05	0.000647	CcSEcCtD
Budesonide—Urethral disorder—Epirubicin—uterine cancer	7.32e-05	0.000645	CcSEcCtD
Budesonide—Epistaxis—Doxorubicin—uterine cancer	7.25e-05	0.00064	CcSEcCtD
Budesonide—Sinusitis—Doxorubicin—uterine cancer	7.22e-05	0.000636	CcSEcCtD
Budesonide—Visual impairment—Epirubicin—uterine cancer	7.19e-05	0.000634	CcSEcCtD
Budesonide—Eye disorder—Epirubicin—uterine cancer	6.97e-05	0.000615	CcSEcCtD
Budesonide—Hypersensitivity—Etoposide—uterine cancer	6.97e-05	0.000615	CcSEcCtD
Budesonide—Haemoglobin—Doxorubicin—uterine cancer	6.94e-05	0.000612	CcSEcCtD
Budesonide—Flushing—Epirubicin—uterine cancer	6.93e-05	0.000611	CcSEcCtD
Budesonide—Cardiac disorder—Epirubicin—uterine cancer	6.93e-05	0.000611	CcSEcCtD
Budesonide—Rhinitis—Doxorubicin—uterine cancer	6.92e-05	0.00061	CcSEcCtD
Budesonide—Haemorrhage—Doxorubicin—uterine cancer	6.9e-05	0.000609	CcSEcCtD
Budesonide—Pharyngitis—Doxorubicin—uterine cancer	6.85e-05	0.000604	CcSEcCtD
Budesonide—Urinary tract disorder—Doxorubicin—uterine cancer	6.82e-05	0.000601	CcSEcCtD
Budesonide—Oedema peripheral—Doxorubicin—uterine cancer	6.8e-05	0.0006	CcSEcCtD
Budesonide—Asthenia—Etoposide—uterine cancer	6.79e-05	0.000598	CcSEcCtD
Budesonide—Connective tissue disorder—Doxorubicin—uterine cancer	6.79e-05	0.000598	CcSEcCtD
Budesonide—Angiopathy—Epirubicin—uterine cancer	6.77e-05	0.000597	CcSEcCtD
Budesonide—Urethral disorder—Doxorubicin—uterine cancer	6.77e-05	0.000597	CcSEcCtD
Budesonide—Immune system disorder—Epirubicin—uterine cancer	6.74e-05	0.000594	CcSEcCtD
Budesonide—Mediastinal disorder—Epirubicin—uterine cancer	6.73e-05	0.000593	CcSEcCtD
Budesonide—Pruritus—Etoposide—uterine cancer	6.69e-05	0.00059	CcSEcCtD
Budesonide—Visual impairment—Doxorubicin—uterine cancer	6.65e-05	0.000587	CcSEcCtD
Budesonide—Alopecia—Epirubicin—uterine cancer	6.59e-05	0.000582	CcSEcCtD
Budesonide—Mental disorder—Epirubicin—uterine cancer	6.54e-05	0.000577	CcSEcCtD
Budesonide—Malnutrition—Epirubicin—uterine cancer	6.5e-05	0.000573	CcSEcCtD
Budesonide—Diarrhoea—Etoposide—uterine cancer	6.47e-05	0.000571	CcSEcCtD
Budesonide—Eye disorder—Doxorubicin—uterine cancer	6.45e-05	0.000569	CcSEcCtD
Budesonide—Cardiac disorder—Doxorubicin—uterine cancer	6.41e-05	0.000565	CcSEcCtD
Budesonide—Flushing—Doxorubicin—uterine cancer	6.41e-05	0.000565	CcSEcCtD
Budesonide—Flatulence—Epirubicin—uterine cancer	6.4e-05	0.000565	CcSEcCtD
Budesonide—Tension—Epirubicin—uterine cancer	6.37e-05	0.000562	CcSEcCtD
Budesonide—Dysgeusia—Epirubicin—uterine cancer	6.36e-05	0.000561	CcSEcCtD
Budesonide—Nervousness—Epirubicin—uterine cancer	6.31e-05	0.000556	CcSEcCtD
Budesonide—Back pain—Epirubicin—uterine cancer	6.28e-05	0.000554	CcSEcCtD
Budesonide—Angiopathy—Doxorubicin—uterine cancer	6.26e-05	0.000552	CcSEcCtD
Budesonide—Dizziness—Etoposide—uterine cancer	6.25e-05	0.000552	CcSEcCtD
Budesonide—Muscle spasms—Epirubicin—uterine cancer	6.25e-05	0.000551	CcSEcCtD
Budesonide—Immune system disorder—Doxorubicin—uterine cancer	6.24e-05	0.00055	CcSEcCtD
Budesonide—Mediastinal disorder—Doxorubicin—uterine cancer	6.22e-05	0.000549	CcSEcCtD
Budesonide—Vision blurred—Epirubicin—uterine cancer	6.12e-05	0.00054	CcSEcCtD
Budesonide—Alopecia—Doxorubicin—uterine cancer	6.1e-05	0.000538	CcSEcCtD
Budesonide—Mental disorder—Doxorubicin—uterine cancer	6.05e-05	0.000533	CcSEcCtD
Budesonide—Ill-defined disorder—Epirubicin—uterine cancer	6.03e-05	0.000532	CcSEcCtD
Budesonide—Vomiting—Etoposide—uterine cancer	6.01e-05	0.00053	CcSEcCtD
Budesonide—Malnutrition—Doxorubicin—uterine cancer	6.01e-05	0.00053	CcSEcCtD
Budesonide—Anaemia—Epirubicin—uterine cancer	6e-05	0.00053	CcSEcCtD
Budesonide—Agitation—Epirubicin—uterine cancer	5.97e-05	0.000526	CcSEcCtD
Budesonide—Rash—Etoposide—uterine cancer	5.96e-05	0.000526	CcSEcCtD
Budesonide—Dermatitis—Etoposide—uterine cancer	5.96e-05	0.000525	CcSEcCtD
Budesonide—Headache—Etoposide—uterine cancer	5.93e-05	0.000523	CcSEcCtD
Budesonide—Flatulence—Doxorubicin—uterine cancer	5.92e-05	0.000522	CcSEcCtD
Budesonide—Tension—Doxorubicin—uterine cancer	5.9e-05	0.00052	CcSEcCtD
Budesonide—Dysgeusia—Doxorubicin—uterine cancer	5.89e-05	0.000519	CcSEcCtD
Budesonide—Malaise—Epirubicin—uterine cancer	5.86e-05	0.000517	CcSEcCtD
Budesonide—Nervousness—Doxorubicin—uterine cancer	5.84e-05	0.000515	CcSEcCtD
Budesonide—Vertigo—Epirubicin—uterine cancer	5.84e-05	0.000515	CcSEcCtD
Budesonide—Syncope—Epirubicin—uterine cancer	5.83e-05	0.000514	CcSEcCtD
Budesonide—Back pain—Doxorubicin—uterine cancer	5.81e-05	0.000513	CcSEcCtD
Budesonide—Muscle spasms—Doxorubicin—uterine cancer	5.78e-05	0.00051	CcSEcCtD
Budesonide—Palpitations—Epirubicin—uterine cancer	5.74e-05	0.000506	CcSEcCtD
Budesonide—Loss of consciousness—Epirubicin—uterine cancer	5.71e-05	0.000504	CcSEcCtD
Budesonide—Cough—Epirubicin—uterine cancer	5.67e-05	0.0005	CcSEcCtD
Budesonide—Vision blurred—Doxorubicin—uterine cancer	5.66e-05	0.0005	CcSEcCtD
Budesonide—Nausea—Etoposide—uterine cancer	5.62e-05	0.000495	CcSEcCtD
Budesonide—Hypertension—Epirubicin—uterine cancer	5.61e-05	0.000495	CcSEcCtD
Budesonide—Ill-defined disorder—Doxorubicin—uterine cancer	5.58e-05	0.000492	CcSEcCtD
Budesonide—Anaemia—Doxorubicin—uterine cancer	5.56e-05	0.00049	CcSEcCtD
Budesonide—Arthralgia—Epirubicin—uterine cancer	5.53e-05	0.000488	CcSEcCtD
Budesonide—Chest pain—Epirubicin—uterine cancer	5.53e-05	0.000488	CcSEcCtD
Budesonide—Myalgia—Epirubicin—uterine cancer	5.53e-05	0.000488	CcSEcCtD
Budesonide—Agitation—Doxorubicin—uterine cancer	5.52e-05	0.000487	CcSEcCtD
Budesonide—Anxiety—Epirubicin—uterine cancer	5.51e-05	0.000486	CcSEcCtD
Budesonide—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—uterine cancer	5.49e-05	0.000484	CcSEcCtD
Budesonide—Discomfort—Epirubicin—uterine cancer	5.46e-05	0.000482	CcSEcCtD
Budesonide—Malaise—Doxorubicin—uterine cancer	5.42e-05	0.000478	CcSEcCtD
Budesonide—Dry mouth—Epirubicin—uterine cancer	5.41e-05	0.000477	CcSEcCtD
Budesonide—Vertigo—Doxorubicin—uterine cancer	5.4e-05	0.000476	CcSEcCtD
Budesonide—Syncope—Doxorubicin—uterine cancer	5.39e-05	0.000475	CcSEcCtD
Budesonide—Confusional state—Epirubicin—uterine cancer	5.35e-05	0.000471	CcSEcCtD
Budesonide—Palpitations—Doxorubicin—uterine cancer	5.31e-05	0.000468	CcSEcCtD
Budesonide—Anaphylactic shock—Epirubicin—uterine cancer	5.3e-05	0.000468	CcSEcCtD
Budesonide—Loss of consciousness—Doxorubicin—uterine cancer	5.28e-05	0.000466	CcSEcCtD
Budesonide—Infection—Epirubicin—uterine cancer	5.27e-05	0.000465	CcSEcCtD
Budesonide—Cough—Doxorubicin—uterine cancer	5.25e-05	0.000463	CcSEcCtD
Budesonide—Shock—Epirubicin—uterine cancer	5.22e-05	0.00046	CcSEcCtD
Budesonide—Nervous system disorder—Epirubicin—uterine cancer	5.2e-05	0.000459	CcSEcCtD
Budesonide—Hypertension—Doxorubicin—uterine cancer	5.19e-05	0.000458	CcSEcCtD
Budesonide—Tachycardia—Epirubicin—uterine cancer	5.17e-05	0.000456	CcSEcCtD
Budesonide—Skin disorder—Epirubicin—uterine cancer	5.15e-05	0.000454	CcSEcCtD
Budesonide—Hyperhidrosis—Epirubicin—uterine cancer	5.13e-05	0.000452	CcSEcCtD
Budesonide—Chest pain—Doxorubicin—uterine cancer	5.12e-05	0.000451	CcSEcCtD
Budesonide—Myalgia—Doxorubicin—uterine cancer	5.12e-05	0.000451	CcSEcCtD
Budesonide—Arthralgia—Doxorubicin—uterine cancer	5.12e-05	0.000451	CcSEcCtD
Budesonide—Anxiety—Doxorubicin—uterine cancer	5.1e-05	0.00045	CcSEcCtD
Budesonide—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—uterine cancer	5.08e-05	0.000448	CcSEcCtD
Budesonide—Discomfort—Doxorubicin—uterine cancer	5.06e-05	0.000446	CcSEcCtD
Budesonide—Anorexia—Epirubicin—uterine cancer	5.05e-05	0.000446	CcSEcCtD
Budesonide—Dry mouth—Doxorubicin—uterine cancer	5e-05	0.000441	CcSEcCtD
Budesonide—Confusional state—Doxorubicin—uterine cancer	4.95e-05	0.000436	CcSEcCtD
Budesonide—Anaphylactic shock—Doxorubicin—uterine cancer	4.91e-05	0.000433	CcSEcCtD
Budesonide—Infection—Doxorubicin—uterine cancer	4.87e-05	0.00043	CcSEcCtD
Budesonide—Musculoskeletal discomfort—Epirubicin—uterine cancer	4.83e-05	0.000426	CcSEcCtD
Budesonide—Shock—Doxorubicin—uterine cancer	4.83e-05	0.000426	CcSEcCtD
Budesonide—Nervous system disorder—Doxorubicin—uterine cancer	4.81e-05	0.000424	CcSEcCtD
Budesonide—Insomnia—Epirubicin—uterine cancer	4.8e-05	0.000423	CcSEcCtD
Budesonide—Tachycardia—Doxorubicin—uterine cancer	4.79e-05	0.000422	CcSEcCtD
Budesonide—Skin disorder—Doxorubicin—uterine cancer	4.77e-05	0.00042	CcSEcCtD
Budesonide—Paraesthesia—Epirubicin—uterine cancer	4.76e-05	0.00042	CcSEcCtD
Budesonide—Hyperhidrosis—Doxorubicin—uterine cancer	4.74e-05	0.000418	CcSEcCtD
Budesonide—Dyspnoea—Epirubicin—uterine cancer	4.73e-05	0.000417	CcSEcCtD
Budesonide—Somnolence—Epirubicin—uterine cancer	4.71e-05	0.000416	CcSEcCtD
Budesonide—Anorexia—Doxorubicin—uterine cancer	4.68e-05	0.000412	CcSEcCtD
Budesonide—Dyspepsia—Epirubicin—uterine cancer	4.67e-05	0.000412	CcSEcCtD
Budesonide—Decreased appetite—Epirubicin—uterine cancer	4.61e-05	0.000406	CcSEcCtD
Budesonide—Gastrointestinal disorder—Epirubicin—uterine cancer	4.58e-05	0.000404	CcSEcCtD
Budesonide—Fatigue—Epirubicin—uterine cancer	4.57e-05	0.000403	CcSEcCtD
Budesonide—Pain—Epirubicin—uterine cancer	4.53e-05	0.0004	CcSEcCtD
Budesonide—Constipation—Epirubicin—uterine cancer	4.53e-05	0.0004	CcSEcCtD
Budesonide—Musculoskeletal discomfort—Doxorubicin—uterine cancer	4.47e-05	0.000394	CcSEcCtD
Budesonide—Insomnia—Doxorubicin—uterine cancer	4.44e-05	0.000391	CcSEcCtD
Budesonide—Paraesthesia—Doxorubicin—uterine cancer	4.41e-05	0.000388	CcSEcCtD
Budesonide—Dyspnoea—Doxorubicin—uterine cancer	4.37e-05	0.000386	CcSEcCtD
Budesonide—Feeling abnormal—Epirubicin—uterine cancer	4.37e-05	0.000385	CcSEcCtD
Budesonide—Somnolence—Doxorubicin—uterine cancer	4.36e-05	0.000385	CcSEcCtD
Budesonide—Gastrointestinal pain—Epirubicin—uterine cancer	4.34e-05	0.000382	CcSEcCtD
Budesonide—Dyspepsia—Doxorubicin—uterine cancer	4.32e-05	0.000381	CcSEcCtD
Budesonide—Decreased appetite—Doxorubicin—uterine cancer	4.26e-05	0.000376	CcSEcCtD
Budesonide—Gastrointestinal disorder—Doxorubicin—uterine cancer	4.24e-05	0.000373	CcSEcCtD
Budesonide—Fatigue—Doxorubicin—uterine cancer	4.23e-05	0.000373	CcSEcCtD
Budesonide—Urticaria—Epirubicin—uterine cancer	4.21e-05	0.000371	CcSEcCtD
Budesonide—Constipation—Doxorubicin—uterine cancer	4.2e-05	0.00037	CcSEcCtD
Budesonide—Pain—Doxorubicin—uterine cancer	4.2e-05	0.00037	CcSEcCtD
Budesonide—Body temperature increased—Epirubicin—uterine cancer	4.19e-05	0.00037	CcSEcCtD
Budesonide—Abdominal pain—Epirubicin—uterine cancer	4.19e-05	0.00037	CcSEcCtD
Budesonide—Feeling abnormal—Doxorubicin—uterine cancer	4.04e-05	0.000357	CcSEcCtD
Budesonide—Gastrointestinal pain—Doxorubicin—uterine cancer	4.01e-05	0.000354	CcSEcCtD
Budesonide—Hypersensitivity—Epirubicin—uterine cancer	3.91e-05	0.000344	CcSEcCtD
Budesonide—Urticaria—Doxorubicin—uterine cancer	3.9e-05	0.000344	CcSEcCtD
Budesonide—Body temperature increased—Doxorubicin—uterine cancer	3.88e-05	0.000342	CcSEcCtD
Budesonide—Abdominal pain—Doxorubicin—uterine cancer	3.88e-05	0.000342	CcSEcCtD
Budesonide—Asthenia—Epirubicin—uterine cancer	3.8e-05	0.000335	CcSEcCtD
Budesonide—Pruritus—Epirubicin—uterine cancer	3.75e-05	0.000331	CcSEcCtD
Budesonide—Diarrhoea—Epirubicin—uterine cancer	3.63e-05	0.00032	CcSEcCtD
Budesonide—Hypersensitivity—Doxorubicin—uterine cancer	3.61e-05	0.000319	CcSEcCtD
Budesonide—Asthenia—Doxorubicin—uterine cancer	3.52e-05	0.00031	CcSEcCtD
Budesonide—Dizziness—Epirubicin—uterine cancer	3.51e-05	0.000309	CcSEcCtD
Budesonide—Pruritus—Doxorubicin—uterine cancer	3.47e-05	0.000306	CcSEcCtD
Budesonide—Vomiting—Epirubicin—uterine cancer	3.37e-05	0.000297	CcSEcCtD
Budesonide—Diarrhoea—Doxorubicin—uterine cancer	3.36e-05	0.000296	CcSEcCtD
Budesonide—Rash—Epirubicin—uterine cancer	3.34e-05	0.000295	CcSEcCtD
Budesonide—Dermatitis—Epirubicin—uterine cancer	3.34e-05	0.000295	CcSEcCtD
Budesonide—Headache—Epirubicin—uterine cancer	3.32e-05	0.000293	CcSEcCtD
Budesonide—Dizziness—Doxorubicin—uterine cancer	3.24e-05	0.000286	CcSEcCtD
Budesonide—Nausea—Epirubicin—uterine cancer	3.15e-05	0.000278	CcSEcCtD
Budesonide—Vomiting—Doxorubicin—uterine cancer	3.12e-05	0.000275	CcSEcCtD
Budesonide—Rash—Doxorubicin—uterine cancer	3.09e-05	0.000273	CcSEcCtD
Budesonide—Dermatitis—Doxorubicin—uterine cancer	3.09e-05	0.000273	CcSEcCtD
Budesonide—Headache—Doxorubicin—uterine cancer	3.07e-05	0.000271	CcSEcCtD
Budesonide—Nausea—Doxorubicin—uterine cancer	2.91e-05	0.000257	CcSEcCtD
